BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9655978)

  • 1. [Involvement of protein tyrosine phosphatases in cancer development].
    Hinoda Y; Idogawa M; Imai K
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1186-92. PubMed ID: 9655978
    [No Abstract]   [Full Text] [Related]  

  • 2. PTEN: sometimes taking it off can be better than putting it on.
    Myers MP; Tonks NK
    Am J Hum Genet; 1997 Dec; 61(6):1234-8. PubMed ID: 9399917
    [No Abstract]   [Full Text] [Related]  

  • 3. [PTEN tumor suppressor: functions as a lipid phosphatase].
    Maehama T; Dixon JE
    Tanpakushitsu Kakusan Koso; 2000 Oct; 45(14):2405-14. PubMed ID: 11051842
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the PTEN/MMAC1 gene in 136 breast cancer families.
    Chen J; Lindblom P; Lindblom A
    Hum Genet; 1998 Jan; 102(1):124-5. PubMed ID: 9490290
    [No Abstract]   [Full Text] [Related]  

  • 5. Landscaping the cancer terrain.
    Kinzler KW; Vogelstein B
    Science; 1998 May; 280(5366):1036-7. PubMed ID: 9616081
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphatases and tumorigenesis.
    Parsons R
    Curr Opin Oncol; 1998 Jan; 10(1):88-91. PubMed ID: 9466490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pten, a candidate tumor suppressor gene, maps to mouse chromosome 19.
    Hansen GM; Justice MJ
    Mamm Genome; 1998 Jan; 9(1):88-90. PubMed ID: 9434957
    [No Abstract]   [Full Text] [Related]  

  • 8. Germline mutations in PTEN are present in Bannayan-Zonana syndrome.
    Marsh DJ; Dahia PL; Zheng Z; Liaw D; Parsons R; Gorlin RJ; Eng C
    Nat Genet; 1997 Aug; 16(4):333-4. PubMed ID: 9241266
    [No Abstract]   [Full Text] [Related]  

  • 9. PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
    Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
    Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN and inherited hamartoma-cancer syndromes.
    Eng C; Peacocke M
    Nat Genet; 1998 Jul; 19(3):223. PubMed ID: 9662392
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer predisposition: where's the phosphate?
    Smith A; Ashworth A
    Curr Biol; 1998 Mar; 8(7):R241-3. PubMed ID: 9545192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
    Tsao H; Zhang X; Benoit E; Haluska FG
    Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
    Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate.
    Dong JT; Sipe TW; Hyytinen ER; Li CL; Heise C; McClintock DE; Grant CD; Chung LW; Frierson HF
    Oncogene; 1998 Oct; 17(15):1979-82. PubMed ID: 9788441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved synteny between the Fugu and human PTEN locus and the evolutionary conservation of vertebrate PTEN function.
    Yu WP; Pallen CJ; Tay A; Jirik FR; Brenner S; Tan YH; Venkatesh B
    Oncogene; 2001 Sep; 20(39):5554-61. PubMed ID: 11571655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression.
    Somerville RP; Shoshan Y; Eng C; Barnett G; Miller D; Cowell JK
    Oncogene; 1998 Oct; 17(13):1755-7. PubMed ID: 9796706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
    Li J; Yen C; Liaw D; Podsypanina K; Bose S; Wang SI; Puc J; Miliaresis C; Rodgers L; McCombie R; Bigner SH; Giovanella BC; Ittmann M; Tycko B; Hibshoosh H; Wigler MH; Parsons R
    Science; 1997 Mar; 275(5308):1943-7. PubMed ID: 9072974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a pseudogene that can masquerade as a mutant allele of the PTEN/MMAC1 tumor suppressor gene.
    Whang YE; Wu X; Sawyers CL
    J Natl Cancer Inst; 1998 Jun; 90(11):859-61. PubMed ID: 9625175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.